Trials / Withdrawn
WithdrawnNCT02497222
Pilot Study of RNS60 in Allergen-induced Bronchoconstriction
Pilot Study of RNS60 in Allergen-induced Bronchconstriction
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Revalesio Corporation · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the use of RNS60 in the treatment of asthma examining regional improvements in inflammation using PET imaging. All subjects will be treated with both RNS60 and placebo in a crossover design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RNS60 | |
| DRUG | Normal Saline |
Timeline
- Primary completion
- 2016-06-01
- First posted
- 2015-07-14
- Last updated
- 2016-10-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02497222. Inclusion in this directory is not an endorsement.